Microneedle patch for local anesthesia and preparation method thereof

Through the design of microneedle patches, the needle tip composed of lidocaine hydrochloride and hyaluronic acid and the substrate of polyvinylpyrrolidone and hyaluronic acid were used to solve the complications and waste treatment problems of puncture injection, and achieve local rapid anesthesia and efficient drug release, improving patient compliance and safety.

CN118948736APending Publication Date: 2024-11-15WUXI MEILING BIOTECHNOLOGY CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411051076.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing local anesthesia methods for puncture injections have complications such as patient fear, nerve damage, hematoma, infection, etc., and it is difficult to treat waste from steel needles as medical sharp devices, which affects treatment compliance and safety.

Method used

Using microneedle patch, the needle tip consists of lidocaine hydrochloride and hyaluronic acid, the base consists of polyvinylpyrrolidone and hyaluronic acid, and is prepared by ultrasonic dissolution and centrifugation filling of the microneedle array mold. The needle tip is 650μm in length and the needle tip is in the epidermal layer. After puncture, the drug is dissolved and released, and the base quickly absorbs water and sticks to the skin to reduce the risk of shedding.

Benefits of technology

It effectively reduces patients' fear of the anesthesia process, improves treatment compliance, reduces adverse reactions, achieves local rapid anesthesia effect, and solves the problem of medical sharp device waste treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948736A_ABST
    Figure CN118948736A_ABST
Patent Text Reader

Abstract

The invention discloses a microneedle patch for local anesthesia and a preparation method thereof. The microneedle patch structurally comprises a needle tip and a substrate, the needle tip is prepared from lidocaine hydrochloride and hyaluronic acid, and the substrate is prepared from polyvinylpyrrolidone and hyaluronic acid; the molecular weight of the hyaluronic acid is 100 to 200 kDa; the polyvinylpyrrolidone is selected from PVP (Polyvinyl Pyrrolidone) K54-K65. The microneedle patch is simple in structure, safe, reliable, good in local anesthesia effect, simple in preparation method and capable of being produced on a large scale.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical inventions, and in particular to a microneedle patch for local anesthesia and a preparation method thereof Background Art

[0002] As a simple, safe, and less complication-prone anesthesia method, local anesthesia is widely used in cosmetic surgery, such as laser vaporization, tissue biopsy, fractional laser therapy, etc. Local anesthesia can block various adverse nerve reactions and reduce stress reactions and pain caused by surgical trauma under the premise of minimal physiological impact on patients. However, there are still many disadvantages of local anesthesia by puncture injection. For example, the steel needles used for puncture injection can easily cause fear in patients and reduce their compliance during the treatment process; the puncture process can easily cause complications such as nerve damage, hematoma, and infection; the steel needles used for injection are medical sharps waste, which creates health and safety risks and medical waste disposal problems.

[0003] Microneedle patch is a new type of patch composed of multiple tiny needle arrays. The tip of the microneedle patch is generally less than 2000 microns. When puncturing, the tip of the needle only punctures the epidermis, but not the dermis containing pain-sensing nerves. Therefore, compared with the traditional method of drug administration by steel needle puncture and injection, microneedle patch administration can significantly reduce the pain during the puncture process and the probability of adverse complications, improve patients' compliance with anesthesia and treatment, and the use of microneedle patches instead of steel needle syringes can effectively solve the safety risks and disposal problems of medical waste.

[0004] As an innovative drug delivery system, the core function of microneedle patches is to ensure accurate drug loading and subsequent controlled release. The drug loading directly determines the therapeutic dose that the patch can provide, while the drug release rate and method are directly related to the distribution and metabolism of the drug in the body, which in turn affects the final therapeutic effect. Therefore, how to optimize the drug loading and release performance of microneedle patches has become a key problem that needs to be solved in the current technical field. Summary of the invention

[0005] In view of the shortcomings of the prior art, the present invention provides a microneedle patch for local anesthesia and a preparation method thereof. The microneedle patch for local anesthesia described in the present invention can effectively reduce the patient's fear of the anesthesia process during the local anesthesia in the treatment process, improve the patient's compliance during the treatment process, and is suitable for the local anesthesia process in various treatment processes such as laser vaporization of superficial tumors, tissue biopsy, and fractional laser treatment.

[0006] The technical solution of the present invention is as follows:

[0007] A microneedle patch for local anesthesia, the structure of the microneedle patch comprising a needle tip and a substrate, the components of the needle tip comprising lidocaine hydrochloride and hyaluronic acid, the components of the substrate comprising polyvinyl pyrrolidone and hyaluronic acid; the molecular weight of the hyaluronic acid is 100-200 kDa; the polyvinyl pyrrolidone is selected from PVP K54-K65.

[0008] Furthermore, the mass ratio of lidocaine hydrochloride to hyaluronic acid in the needle tip is 2-4:10.

[0009] Furthermore, the mass ratio of hyaluronic acid to polyvinyl pyrrolidone in the substrate is 1-3:5.

[0010] A method for preparing the microneedle patch, the method comprising the following steps:

[0011] (1) preparing a hyaluronic acid solution;

[0012] (2) adding lidocaine hydrochloride to the hyaluronic acid solution and dissolving it by ultrasonication to obtain a needle tip solution;

[0013] (3) adding polyvinyl pyrrolidone to the hyaluronic acid solution and dissolving it by ultrasonication to obtain a base solution;

[0014] (4) Add the needle tip solution obtained in step (2) to the microneedle array mold, centrifuge, fill the needle tip solution in the needle tip part of the microneedle array mold, then add the base solution obtained in step (3), centrifuge again, dry, demold, and obtain the microneedle patch after ultraviolet sterilization.

[0015] Furthermore, in step (1), the preparation method of the hyaluronic acid solution is: adding hyaluronic acid to sterile water, and obtaining the hyaluronic acid solution after ultrasonic treatment; the power of the ultrasonic treatment is 100-300W, and the time is 10-30min; the mass volume ratio of the hyaluronic acid to the sterile water is 0.1g:1mL.

[0016] Furthermore, in step (2), the mass volume ratio of lidocaine hydrochloride to hyaluronic acid solution is 0.01-0.05 g:1 mL; the power of the ultrasound is 90-300 W, and the time is 10-30 min.

[0017] Furthermore, in step (3), the preparation method of the hyaluronic acid solution is: adding hyaluronic acid to sterile water, and obtaining the hyaluronic acid solution after ultrasonic treatment; the power of the ultrasonic treatment is 100-300W, and the time is 10-30min; the mass volume ratio of the hyaluronic acid to the sterile water is 0.02-0.07g:1mL; the mass volume ratio of the polyvinyl pyrrolidone to the hyaluronic acid solution is 0.050-0.200g:1mL; the power of the ultrasonic treatment is 100-300W, and the time is 10-30min.

[0018] Furthermore, in step (4), the volume ratio of the needle tip solution to the base solution is 1:1-2.

[0019] Furthermore, in step (4), the volume ratio of the needle tip solution to the base solution is preferably 1:1.

[0020] Furthermore, in step (4), the centrifugal speed is 3500-4000 rpm, and the time is 5-20 min; the ultraviolet sterilization time is 25-30 min.

[0021] A microneedle patch or a microneedle patch prepared by the preparation method, characterized in that the length of the microneedle tips of the microneedle patch is 650 μm.

[0022] The beneficial technical effects of the present invention are:

[0023] The microneedle patch for local anesthesia prepared by the present invention is suitable for local anesthesia in various treatment processes such as laser vaporization of superficial tumors, tissue biopsy, and fractional laser treatment. The length of the microneedle tip is controllable, and the tip is composed of effective anesthetic components, lidocaine hydrochloride and hyaluronic acid; the needle bottom is composed of adhesive components, polyvinyl pyrrolidone and hyaluronic acid. The microneedle has a simple structure, is safe and reliable, has a good local anesthesia effect, and has a simple preparation method and can be mass-produced. The tip of the local anesthesia microneedle patch in the present invention can dissolve and release lidocaine hydrochloride for local anesthesia after piercing the superficial epidermis, and the needle bottom can quickly absorb water and adhere to the skin after piercing to reduce the possibility of microneedle shedding during patient activities. Since the tip of the microneedle only punctures the epidermis during the process of microneedle piercing the skin, and does not pierce the dermis containing pain nerves, there is almost no pain, so the use of the microneedle patch in the present invention for local anesthesia during treatment can effectively reduce the patient's fear of the anesthesia process and improve the patient's compliance during treatment.

[0024] The present invention improves the dissolution rate of microneedles by deeply studying the material selection of microneedle patches and optimizing the types and relative amounts of the components of the microneedle patches, so that the drugs loaded by the microneedles can be quickly released, thereby improving the efficiency of microneedle dissolution and drug delivery, and achieving the effect of local rapid anesthesia. In addition, the needle tip of the microneedle patch of the present invention uses only hyaluronic acid, which can ensure safety, reduce adverse reactions, and promote the recovery of wounds caused by microneedle puncture. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 The present invention is a flow chart of the preparation of the microneedle patch.

[0026] Figure 2 This is an appearance morphology picture of the microneedle patch prepared in Example 1-2 of the present invention.

[0027] In the figure: (a) the microneedle patch prepared in Example 1; (b) the microneedle patch prepared in Example 2.

[0028] Figure 3 This is a SEM image of the microneedle patch prepared in Example 1-2 of the present invention.

[0029] In the figure: (a) the microneedle patch prepared in Example 1; (b) the microneedle patch prepared in Example 2.

[0030] Figure 4 This is a Fourier transform infrared spectrum of the microneedle patch prepared in Example 1 of the present invention.

[0031] Figure 5 Graph showing the relationship between displacement and bearing capacity of the microneedle patch prepared in Example 1-2 of the present invention.

[0032] In the figure: (a) is a diagram showing the relationship between the displacement and the bearing capacity of the microneedle patch prepared in Example 1; (b) is a diagram showing the relationship between the displacement and the bearing capacity of the microneedle patch prepared in Example 2. DETAILED DESCRIPTION

[0033] The present invention is described in detail below in conjunction with the accompanying drawings and embodiments.

[0034] The preparation process of the microneedle patch of the present invention is as follows Figure 1 As shown, the prepared needle tip solution is dripped into the microneedle array mold, and after centrifugation, the needle tip solution is sunk to the bottom of the microneedle mold, and then the prepared base solution is dripped into the microneedle array mold, centrifuged again, dried, and demolded to obtain a microneedle patch.

[0035] In the following examples, lidocaine hydrochloride was purchased from Shanghai MacLean Biochemical Technology Co., Ltd. with a product number of L832376;

[0036] Polyvinyl pyrrolidone (PVP K54-K65) brand is Anaiji, product number is A050762;

[0037] Hyaluronic acid (molecular weight Mw = 100-200 kDa) was purchased from Shanghai MacLean Biochemical Technology Co., Ltd. with the catalog number H909935.

[0038] Example 1

[0039] A microneedle patch for local anesthesia, the preparation method of which is as follows:

[0040] (1) 5 g and 2.5 g of hyaluronic acid (molecular weight Mw = 100-200 kDa) were added to 50 mL of sterile water, respectively, and ultrasonicated at 100 W for 25 min to obtain hyaluronic acid solutions of 0.1 g / mL and 0.05 g / mL, respectively.

[0041] (2) 1.5 g of lidocaine hydrochloride and 50 mL of 0.1 g / mL hyaluronic acid solution were mixed and ultrasonicated at 90 W for 25 min to obtain a needle tip solution.

[0042] (3) 6.25 g of polyvinylpyrrolidone PVP K54-K65 and 50 mL of 0.05 g / mL hyaluronic acid solution were mixed and ultrasonicated at a power of 100 W for 25 min to obtain a base solution.

[0043] (4) According to Figure 1 In the process, 0.4 mL of needle tip solution was injected into the microneedle array mold (the holes of the microneedle array mold were conical holes, the number of holes was 34×34, the hole depth was 650 μm, the maximum hole diameter was 300 μm, and the needle tip distance was 600 μm), and the needle tip solution was filled in the needle tip part of the microneedle array mold at a speed of 4000 rpm for 20 minutes. After the centrifugation, the residual needle tip solution on the PDMS mold base layer was removed; then 2 mL of base solution was added to the PDMS mold base layer, and the base solution was filled in the base part of the microneedle array mold at a speed of 3500 rpm for 20 minutes; it was dried at room temperature for 20 hours, and finally demolded, and irradiated under ultraviolet light for 30 minutes to obtain a microneedle patch for local anesthesia.

[0044] Example 2

[0045] A microneedle patch for local anesthesia, the preparation method of which is as follows:

[0046] (1) 5 g and 2.5 g of hyaluronic acid (molecular weight Mw = 100-200 k) were added to 50 mL of sterile water, respectively, and ultrasonicated at 100 W for 25 min to obtain hyaluronic acid solutions of 0.1 g / mL and 0.05 g / mL, respectively.

[0047] (2) 1.5 g of lidocaine hydrochloride and 50 mL of 0.1 g / mL hyaluronic acid solution were mixed and ultrasonicated at 100 W for 25 min to obtain a needle tip solution.

[0048] (3) 6.25 g of polyvinylpyrrolidone PVP K54-K65 and 50 mL of 0.05 g / mL hyaluronic acid solution were mixed and ultrasonicated at a power of 100 W for 25 min to obtain a base solution.

[0049] (4) According to Figure 1In the process, 0.2mL of needle tip solution was injected into the microneedle array mold (the holes of the microneedle array mold were conical holes, the number of holes was 10×10, the hole depth was 650μm, the maximum hole diameter was 300μm, and the needle tip distance was 600μm), and centrifuged at 4000rpm for 10min to fill the needle tip solution in the needle tip part of the microneedle array mold. After centrifugation, the residual needle tip solution on the PDMS mold base layer was removed; then 0.5mL of base solution was added to the PDMS mold base layer, and centrifuged at 3500rpm for 5min to fill the base solution in the base part of the microneedle array mold; dried at room temperature for 20h, finally demolded, and irradiated under ultraviolet light for 30min to obtain a microneedle patch for local anesthesia.

[0050] Example 3

[0051] A microneedle patch for local anesthesia, the preparation method of which is as follows:

[0052] (1) 5 g and 2.5 g of hyaluronic acid (molecular weight Mw = 100-200 kDa) were added to 50 mL of sterile water, respectively, and ultrasonicated at 100 W for 25 min to obtain hyaluronic acid solutions of 0.1 g / mL and 0.05 g / mL, respectively.

[0053] (2) 1.0 g of lidocaine hydrochloride and 50 mL of 0.1 g / mL hyaluronic acid solution were mixed and ultrasonicated at 200 W for 20 min to obtain a needle tip solution.

[0054] (3) 12.5 g of polyvinylpyrrolidone PVP K54-K65 and 50 mL of 0.05 g / mL hyaluronic acid solution were mixed and ultrasonicated at 200 W for 20 min to obtain a base solution.

[0055] (4) According to Figure 1 In the process, 0.4 mL of needle tip solution was injected into the microneedle array mold (the holes of the microneedle array mold were conical holes, the number of holes was 34×34, the hole depth was 650 μm, the maximum hole diameter was 300 μm, and the needle tip distance was 600 μm), and the needle tip solution was filled in the needle tip part of the microneedle array mold at a speed of 4000 rpm for 20 minutes. After the centrifugation, the residual needle tip solution on the PDMS mold base layer was removed; then 2 mL of base solution was added to the PDMS mold base layer, and the base solution was filled in the base part of the microneedle array mold at a speed of 3500 rpm for 20 minutes; it was dried at room temperature for 20 hours, and finally demolded, and irradiated under ultraviolet light for 25 minutes to obtain a microneedle patch for local anesthesia.

[0056] Example 4

[0057] A microneedle patch for local anesthesia, the preparation method of which is as follows:

[0058] (1) 5 g and 2.5 g of hyaluronic acid (molecular weight Mw = 100-200 kDa) were added to 50 mL of sterile water, respectively, and ultrasonicated at 100 W for 25 min to obtain hyaluronic acid solutions of 0.1 g / mL and 0.05 g / mL, respectively.

[0059] (2) 2.0 g of lidocaine hydrochloride and 50 mL of 0.1 g / mL hyaluronic acid solution were mixed and ultrasonicated at 300 W for 10 min to obtain a needle tip solution.

[0060] (3) 4.16 g of polyvinylpyrrolidone PVP K54-K65 and 50 mL of 0.05 g / mL hyaluronic acid solution were mixed and ultrasonicated at 300 W for 10 min to obtain a base solution.

[0061] (4) According to Figure 1 In the process, 0.4 mL of needle tip solution was injected into the microneedle array mold (the holes of the microneedle array mold were conical holes, the number of holes was 34×34, the hole depth was 650 μm, the maximum hole diameter was 300 μm, and the needle tip distance was 600 μm), and the needle tip solution was filled in the needle tip part of the microneedle array mold at a speed of 4000 rpm for 20 minutes. After the centrifugation, the residual needle tip solution on the PDMS mold base layer was removed; then 2 mL of base solution was added to the PDMS mold base layer, and the base solution was filled in the base part of the microneedle array mold at a speed of 3500 rpm for 20 minutes; it was dried at room temperature for 20 hours, and finally demolded, and irradiated under ultraviolet light for 30 minutes to obtain a microneedle patch for local anesthesia.

[0062] Test Case

[0063] (1) Morphology and structure of microneedle patches for local anesthesia

[0064] The microneedle patch for local anesthesia prepared in Example 1-2 of the present invention was placed on a table and photographed. The results are as follows: Figure 2 The microneedle patch for local anesthesia prepared in Example 1-2 of the present invention was observed by a Japanese JSM-6330F scanning electron microscope. The results are as follows Figure 3 shown.

[0065] from Figure 2 The results show that there is no obvious damage on the appearance of the microneedles, and the microneedle tip array is arranged neatly.

[0066] from Figure 3 The results show that the microneedle has a complete microscopic morphology and a sharp needle tip.

[0067] (2) Composition analysis of microneedle patches for local anesthesia

[0068] The microneedle patch for local anesthesia prepared in Example 1 of the present invention was taken and its infrared spectra at 4000-500 cm were detected by a Thermo Nicolet iS10 Fourier transform infrared spectrometer. -1 The Fourier transform infrared spectrum of the wavelength range is as follows Figure 4 As shown. Figure 4 The results show that the infrared peak at 3372 cm -1 、1374cm -1 、1019cm -1 Caused by hydroxyl OH, secondary amine CN, COC in hyaluronic acid, infrared peak 1643cm -1 、1374cm -1 、1288cm -1 、1217cm -1 、798cm -1 It is caused by the carbonyl C=O, secondary amine CN, tertiary amine CN, benzene ring skeleton CH, and benzene ring skeleton CH in lidocaine hydrochloride. The infrared peak is 1643cm -1 、1421cm -1 、1288cm -1 It is caused by the carbonyl group C=O, alkyl group CH and tertiary amine CN in polyvinylpyrrolidone.

[0069] (3) Mechanical properties of microneedle patches for local anesthesia

[0070] Take the microneedle patch for local anesthesia prepared in Example 1-2 of the present invention, fix it to the center of the base of the universal testing platform for mechanical properties of ZQ-990L materials, with the needle tip facing the upper platform. During the test, the platform is slowly pressed down, and the instrument automatically records the curve of displacement and force. The results are as follows: Figure 5 As shown. Figure 5 The results show that the mechanical properties of the microneedle meet the requirement of a force > 0.18N for penetrating the skin, indicating that the microneedle body prepared by the present invention can carry the drug and completely penetrate the skin to achieve precise drug delivery.

[0071] (4) Drug delivery efficiency of microneedle patches for local anesthesia

[0072] The microneedle patch for local anesthesia prepared in Examples 1-2 of the present invention was taken. Through the microneedle mechanical property test, it can be found that the microneedle prepared in Examples 1-2 of the present invention can fully reach the maximum displacement under the condition of a force >0.18N, so that the needle tip completely penetrates and sinks below the surface of the skin, and the needle tip stays completely inside the skin tissue. The drug loaded in the needle tip can be completely dissolved and released. Therefore, the drug delivery efficiency of the microneedle patch prepared in Examples 1-2 of the present invention is 100%.

[0073] The relative molecular weight of hyaluronic acid in Example 1-2 of the present invention is higher than that of the compound lidocaine microneedle of Chinese patent CN202210298919.8, which makes it easier to prepare the microneedle; the base components of Example 1-2 are hyaluronic acid and polyvinyl pyrrolidone K54-K65. Compared with the base components of the compound lidocaine microneedle of Chinese patent CN202210298919.8, which are hyaluronic acid, polyvinyl alcohol and dextran, the components of Example 1-2 of the present invention are more streamlined, and polyvinyl pyrrolidone K54-K65 makes the base part of the microneedle patch have better skin adhesion. The needle tip components of the compound lidocaine microneedle of Chinese patent CN202210298919.8 contain, in addition to lidocaine hydrochloride and prilocaine hydrochloride for anesthetic effects, hyaluronic acid, chondroitin sulfate and polyvinyl pyrrolidone. The complex composition makes the needle tip difficult to prepare. The needle tip part of Examples 1-2 of the present invention uses a simple and refined component, lidocaine hydrochloride, to act as an anesthetic and analgesic, which is mixed with hyaluronic acid to form the needle tip part. The mechanical properties have been tested to have good mechanical properties, thereby achieving complete dissolution and release of the drug loaded in the needle tip.

[0074] The above is only a preferred embodiment of the present invention, and the present invention is not limited to the above embodiments. It is understood that other improvements and changes directly derived or associated by those skilled in the art without departing from the spirit and concept of the present invention should be considered to be included in the protection scope of the present invention.

Claims

1. A microneedle patch for local anesthesia, It is characterized in that The structure of the microneedle patch includes a needle tip and a substrate. The components of the needle tip include lidocaine hydrochloride and hyaluronic acid, and the components of the substrate include polyvinyl pyrrolidone and hyaluronic acid. The molecular weight of the hyaluronic acid is 100-200 kDa. The polyvinyl pyrrolidone is selected from PVP K54-K65.

2. The microneedle patch according to claim 1, It is characterized in that The mass ratio of lidocaine hydrochloride to hyaluronic acid in the needle tip is 2-4:

10.

3. The microneedle patch according to claim 1, It is characterized in that The mass ratio of hyaluronic acid to polyvinyl pyrrolidone in the substrate is 1-3:

5.

4. A method for preparing the microneedle patch according to any one of claims 1 to 3, It is characterized in that The preparation method comprises the following steps: (1) preparing a hyaluronic acid solution; (2) adding lidocaine hydrochloride to the hyaluronic acid solution and dissolving it by ultrasonication to obtain a needle tip solution; (3) adding polyvinyl pyrrolidone to the hyaluronic acid solution and dissolving it by ultrasonication to obtain a base solution; (4) Add the needle tip solution obtained in step (2) to the microneedle array mold, centrifuge, fill the needle tip solution in the needle tip part of the microneedle array mold, then add the base solution obtained in step (3), centrifuge again, dry, demold, and obtain the microneedle patch after ultraviolet sterilization.

5. The preparation method according to claim 4, It is characterized in that In step (1), the preparation method of the hyaluronic acid solution is: adding hyaluronic acid to sterile water, and obtaining the hyaluronic acid solution after ultrasonic treatment; the power of the ultrasonic treatment is 100-300W, and the time is 10-30min; the mass volume ratio of the hyaluronic acid to the sterile water is 0.1g:1mL.

6. The preparation method according to claim 4, It is characterized in that In step (2), the mass volume ratio of lidocaine hydrochloride to hyaluronic acid solution is 0.01-0.05 g:1 mL; the power of the ultrasound is 90-300 W, and the time is 10-30 min.

7. The preparation method according to claim 4, It is characterized in that In step (3), the preparation method of the hyaluronic acid solution is: adding hyaluronic acid to sterile water, and obtaining the hyaluronic acid solution after ultrasonic treatment; the power of the ultrasonic treatment is 100-300W, and the time is 10-30min; the mass volume ratio of the hyaluronic acid to the sterile water is 0.02-0.07g:1mL; the mass volume ratio of the polyvinyl pyrrolidone to the hyaluronic acid solution is 0.050-0.200g:1mL; the power of the ultrasonic treatment is 100-300W, and the time is 10-30min.

8. The preparation method according to claim 4, It is characterized in that In step (4), the volume ratio of the needle tip solution to the base solution is 1:1-2.

9. The preparation method according to claim 4, It is characterized in that In step (4), the centrifugal speed is 3500-4000 rpm, and the time is 5-20 min; the ultraviolet sterilization time is 25-30 min.

10. A microneedle patch according to any one of claims 1 to 3 or a microneedle patch prepared by the preparation method according to any one of claims 4 to 5, It is characterized in that The length of the microneedle tips of the microneedle patch is 650 μm.

Citation Information

Patent Citations

  • Compound lidocaine microneedle patch for easing pain

    CN114869861A